Navigation Links
Thomson Reuters Joins the InChI Trust

PHILADELPHIA and LONDON, Aug. 18 /PRNewswire/ --Thomson Reuters today announced that they have joined the InChI Trust, a not-for-profit organization to expand and develop the InChI Open Source chemical structure representation algorithm. The algorithm provides a consistent, credible and compatible way for databases of chemical structures to be linked together for the benefit of users of chemical information around the world.

"We are committed to supporting the InChI Trust and InChI initiative," said Dr. Josep Prous, Jr., Vice President and Chief Scientific Officer at Thomson Reuters. "The latest version of Prous Science Integrity(R) drug discovery database adds InChI's and InChIKeys to the more than 370,000 drugs and intermediates covered, facilitating access to and communication of information in the chemistry community."

Support of the InChI initiative and the adoption of InChI's within Prous Science Integrity(R) will further chemistry users' ability to integrate information across multiple sources and communicate this information in a consistent way across the globe.

"We are delighted to welcome Thomson Reuters as a member of the InChI Trust," says Project Leader Dr. Stephen Heller. "We value their support, as specialists within the chemical information industry, to continue to develop the InChI and InChIKey standards to enable wide scale linking of chemical information."

Prous Science Integrity seamlessly integrates biological, chemical and pharmacological information on more than 300,000 compounds with demonstrated biological activity, plus tens of thousands of synthesis intermediates and over 125,000 patent family records. Updated daily, this unique database is designed to empower your drug discovery and development activities. Find out more about Prous Science Integrity here.

Thomson Reuters will be attending the 238(th) American Chemical Society's National Meeting and Exposition, August 16-20, 2009 in Washington, DC and ChemOutsourcing, September 14-16, 2009 in Long Branch, NJ. Researchers are encouraged to come and receive a demonstration of the latest changes to Prous Science Integrity.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to

SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
2. Thomson Reuters Partners With Sagient Research
3. Brazils Scientific Research On The Rise, Thomson Reuters Study Finds
4. Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
5. Thomson Reuters Examines Highly Cited Research in Bioterrorism
6. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
7. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
8. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
9. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
10. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
11. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
Post Your Comments:
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology:
(Date:4/18/2017)... April 18, 2017  Socionext Inc., a global expert in SoC-based ... edge server, the M820, which features the company,s hybrid codec technology. ... by Tera Probe, Inc., will be showcased during the upcoming Medtec ... show at the Las Vegas Convention Center ... Click here ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
Breaking Biology News(10 mins):